Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Aug 15;15(1):260.
doi: 10.1186/s13287-024-03801-5.

Clinical and preclinical approach in AGA treatment: a review of current and new therapies in the regenerative field

Lorena Pozo-Pérez  1   2 , Pilar Tornero-Esteban  3 , Eduardo López-Bran  4
Affiliations
Review

Clinical and preclinical approach in AGA treatment: a review of current and new therapies in the regenerative field

Lorena Pozo-Pérez et al. Stem Cell Res Ther. .

Abstract

Androgenetic alopecia (AGA) is the most prevalent type of hair loss. Its morbility is mainly psychological although an increased incidence in melanoma has also been observed in affected subjects. Current drug based therapies and physical treatments are either unsuccessful in the long term or have relevant side effects that limit their application. Therefore, a new therapeutic approach is needed to promote regenerative enhancement alternatives. These treatment options, focused on the cellular niche restoration, could be the solution to the impact of dihydrotestosterone in the hair follicle microenvironment. In this context emerging regenerative therapies such as Platelet-rich plasma or Platelet-rich fibrine as well as hair follicle stem cells and mesenchymal stem cell based therapies and their derivatives (conditioned medium CM or exoxomes) are highlighting in the evolving landscape of hair restoration. Nanotechnology is also leading the way in AGA treatment through the design of bioinks and nanobiomaterials whose structures are being configuring in a huge range of cases by means of 3D bioprinting. Due to the increasing number and the rapid creation of new advanced therapies alternatives in the AGA field, an extended review of the current state of art is needed. In addition this review provides a general insight in current and emerging AGA therapies which is intented to be a guidance for researchers highlighting the cutting edge treatments which are recently gaining ground.

Keywords: Androgenetic alopecia; Bioinks; Cell therapy; Conditioned medium; Hair growth; Nanomaterials; Stem cells.

PubMed Disclaimer

Conflict of interest statement

They authors declare that they have no competing interests.

References

    1. Blumeyer A, Tosti A, Messenger A, Reygagne P, del Marmol V, Spuls PI, et al. Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men. JDDG J der Dtsch Dermatologischen Gesellschaft. 2011;9:1–57. 10.1111/j.1610-0379.2011.07802.x. 10.1111/j.1610-0379.2011.07802.x - DOI - PubMed
    1. Hamilton JB. Patterned loss of hair in man: types and incidence. Ann N Y Acad Sci. 1951;53(3):708–28. 10.1111/j.1749-6632.1951.tb31971.x. 10.1111/j.1749-6632.1951.tb31971.x - DOI - PubMed
    1. Ramos PM, Miot HA. Female pattern hair loss: a clinical and pathophysiological review. An Bras Dermatol. 2015;90(4):529–43. 10.1590/abd1806-4841.20153370 - DOI - PMC - PubMed
    1. Gentile G. Advances in regenerative stem cell therapy in androgenic alopecia and hair loss: wnt pathway, growth-factor, and mesenchymal stem cell signaling impact analysis on cell growth and hair follicle development. Cells. 2019;8(5):466. 10.3390/cells8050466 - DOI - PMC - PubMed
    1. Ellis JA, Sinclair R, Harrap SB. Androgenetic alopecia: pathogenesis and potential for therapy. Expert Rev Mol Med. 2002;4(22):1–11. 10.1017/S1462399402005112 - DOI - PubMed

LinkOut - more resources